The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
WBC characterisation to support the development of engineered regulatory T cells.
Timeframe: 5 years